PEDEvidence
Semaglutide research
Human

What did the direct comparison with liraglutide show?

15.8% weight reduction

338 adults; semaglutide 2.4 mg weekly versus liraglutide 3 mg daily.

Demonstrated findings

Mean weight reduction was 15.8% with semaglutide and 6.4% with liraglutide at 68 weeks.

Limitations & adverse findings

Gastrointestinal events were common in both groups.

What might this mean? · interpretation

This directly compares the two studied regimens for weight loss.

What might this mean, and what would change the interpretation?

Open-label comparison in adults without diabetes; other doses and outcomes need separate evidence.

What would clarify this: Longer follow-up and matched body-composition outcomes.

Findings reviewed · abstract

Checked Sep 15, 2026 against the linked abstract. This reading note is not a formal risk-of-bias appraisal.

Download evidence card

An editorial reading note with a primary-source link. Interpretation is identified separately from observed results.